National Data Analysis and Systematic Review for Human Resources for Cervical Cancer Screening in Japan.
Cervical cancer
Pap smear
Smear taker
cancer screening
gynecologist
Journal
Asian Pacific journal of cancer prevention : APJCP
ISSN: 2476-762X
Titre abrégé: Asian Pac J Cancer Prev
Pays: Thailand
ID NLM: 101130625
Informations de publication
Date de publication:
01 Jun 2021
01 Jun 2021
Historique:
received:
13
01
2021
entrez:
28
6
2021
pubmed:
29
6
2021
medline:
15
12
2021
Statut:
epublish
Résumé
Although cervical cancer screening has been performed as a national program since 1983 in Japan, the participation rate has remained below 20%. Equity of access is a basic requirement for cancer screening. However, taking smears from the cervix has been limited to gynecologists or obstetricians in Japan and it might be a barrier for accessibility. We examined the current access and its available human resources for cervical cancer screening in Japan. We analyzed the number of gynecologists and obstetricians among 47 prefectures based on a national survey. A systematic review was performed to clarify disparity and use of human resources in cervical cancer screening, diagnosis, and treatment for cervical cancers in Japan. Candidate literature was searched using Ovid-MEDLINE and Ichushi-Web until the end of January 2020. Then, a systematic review regarding accessibility to cervical cancer screening was performed. The results of the selected articles were summarized in the tables. Although the total number of all physicians in Japan increased from 1996 to 2016, the proportion of gynecologists and obstetricians has remained at approximately 5% over the last 2 decades. 43.6% of municipalities have no gynecologists and obstetricians in 2016. Through a systematic review, 4 English articles and 1 Japanese article were selected. From these 5 articles, the association between human resources and participation rates in cervical cancer screening was examined in 2 articles. The human resources for taking smears for cervical cancer screening has remained insufficient with a huge disparity among municipalities in Japan. To improve accessibility for cervical cancer screening another option which may be considered could be involving general physicians as potential smear takers.
Sections du résumé
BACKGROUND
BACKGROUND
Although cervical cancer screening has been performed as a national program since 1983 in Japan, the participation rate has remained below 20%. Equity of access is a basic requirement for cancer screening. However, taking smears from the cervix has been limited to gynecologists or obstetricians in Japan and it might be a barrier for accessibility. We examined the current access and its available human resources for cervical cancer screening in Japan.
METHODS
METHODS
We analyzed the number of gynecologists and obstetricians among 47 prefectures based on a national survey. A systematic review was performed to clarify disparity and use of human resources in cervical cancer screening, diagnosis, and treatment for cervical cancers in Japan. Candidate literature was searched using Ovid-MEDLINE and Ichushi-Web until the end of January 2020. Then, a systematic review regarding accessibility to cervical cancer screening was performed. The results of the selected articles were summarized in the tables.
RESULTS
RESULTS
Although the total number of all physicians in Japan increased from 1996 to 2016, the proportion of gynecologists and obstetricians has remained at approximately 5% over the last 2 decades. 43.6% of municipalities have no gynecologists and obstetricians in 2016. Through a systematic review, 4 English articles and 1 Japanese article were selected. From these 5 articles, the association between human resources and participation rates in cervical cancer screening was examined in 2 articles.
CONCLUSIONS
CONCLUSIONS
The human resources for taking smears for cervical cancer screening has remained insufficient with a huge disparity among municipalities in Japan. To improve accessibility for cervical cancer screening another option which may be considered could be involving general physicians as potential smear takers.
Identifiants
pubmed: 34181323
doi: 10.31557/APJCP.2021.22.6.1695
pmc: PMC8418842
pii:
doi:
Types de publication
Journal Article
Review
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1695-1702Références
Eur J Cancer. 2015 May;51(8):950-68
pubmed: 25817010
Int J Cancer. 2019 Jan 1;144(1):89-97
pubmed: 29943822
J Obstet Gynaecol Res. 2016 May;42(5):481-8
pubmed: 26988808
Eur J Cancer Prev. 2016 Nov;25(6):547-55
pubmed: 26628087
Am J Prev Med. 2014 Sep;47(3):315-9
pubmed: 24953518
Cytopathology. 2007 Jun;18(3):133-9
pubmed: 17573762
Gastroenterology. 2004 Dec;127(6):1661-9
pubmed: 15578502
BMC Public Health. 2016 May 24;16:431
pubmed: 27220976
Acta Obstet Gynecol Scand. 2007;86(6):742-8
pubmed: 17520410
Cancer. 2016 Aug 15;122(16):2479-86
pubmed: 27200481
Gastroenterology. 2004 Dec;127(6):1670-7
pubmed: 15578503
Jpn J Clin Oncol. 2018 Mar 1;48(3):278-286
pubmed: 29315389
PLoS One. 2016 Oct 12;11(10):e0164666
pubmed: 27732635
Can J Gastroenterol. 2007 Jun;21(6):371-7
pubmed: 17571171
BMJ. 2018 Dec 5;363:k4823
pubmed: 30518635
Ir J Med Sci. 2001 Jul-Sep;170(3):186-8
pubmed: 12120972
BMC Cancer. 2012 Jan 26;12:46
pubmed: 22280408
PLoS One. 2017 Jul 13;12(7):e0180819
pubmed: 28704430
Bull World Health Organ. 2008 Apr;86(4):317-9
pubmed: 18438522
Ann Intern Med. 2009 Nov 3;151(9):602-11
pubmed: 19884621
Asian Pac J Cancer Prev. 2014;15(6):2607-12
pubmed: 24761871
J Gynecol Oncol. 2018 Mar;29(2):e23
pubmed: 29400016
J Obstet Gynaecol Res. 2019 Jun;45(6):1160-1166
pubmed: 30843312
Cancer Sci. 2017 Jan;108(1):101-107
pubmed: 27727490
Lancet Oncol. 2019 Feb;20(2):229-238
pubmed: 30658933
J Natl Cancer Inst. 2012 Feb 8;104(3):178-88
pubmed: 22271765